title: Restrained molecular dynamics studies on complex of adriamycin with DNA hexamer sequence d-CGATCG.
abstract: Adriamycin is an anthracycline anticancer drug used widely for solid tumors in spite of its adverse side effects. The solution structure of 2:1 adriamycin-d-(CGATCG)(2) complex has been studied by restrained molecular dynamics simulations. The restraint data set consists of several intramolecular and intermolecular nuclear Overhauser enhancement cross-peaks obtained from two-dimensional nuclear magnetic resonance spectroscopy data. The drug is found to intercalate between CG and GC base pairs at two d-CpG sites. The drug-DNA complex is stabilized via specific hydrogen bonding and van der Waal's interactions involving 4OCH(3), O5, 6OH, and NH(3)(+) moiety of daunosamine sugar, and rings A protons. The O-glycosidic bond C7-O7-C1'-C2' lies in the range 138 degrees -160 degrees during the course of simulations. The O6-H6...O5 hydrogen bond is stable while O11-H11...O12 hydrogen bond is not favored. The intercalating base pairs are buckled and minor groove is wider in the complex. The phosphate on one strand at intercalation site C1pG2 is in B(I) conformation and the phosphates directly lying on opposite strand is in B(II) conformation. The phosphorus on adjacent site G2pA3 is in B(II) conformation and hence a distinct pattern of B(I) and B(II) conformations is induced and stabilized. The role of various functional groups by which the molecular action is mediated has been discussed and correlated to the available biochemical evidence.
authors.affiliation: Department of Biotechnology, Indian Institute of Technology Roorkee, Roorkee 247 667, India.
authors.forename: Monica
authors.initials: M
authors.lastname: Jain
authors.forename: Sudhir Kumar
authors.initials: SK
authors.lastname: Barthwal
authors.forename: Ritu
authors.initials: R
authors.lastname: Barthwal
authors.forename: Girjesh
authors.initials: G
authors.lastname: Govil
mesh_terms: D004317:Doxorubicin / Q000737:chemistry* / Q000627:therapeutic use; D006801:Humans; D006860:Hydrogen Bonding; D007364:Intercalating Agents / Q000737:chemistry* / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy; D019906:Nuclear Magnetic Resonance, Biomolecular; D009690:Nucleic Acid Conformation; D009838:Oligodeoxyribonucleotides / Q000737:chemistry*
chemical_list: D007364:Intercalating Agents; D009838:Oligodeoxyribonucleotides; D004317:Doxorubicin